These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8388821)

  • 41. Synthetic poliovirus and other designer viruses: what have we learned from them?
    Wimmer E; Paul AV
    Annu Rev Microbiol; 2011; 65():583-609. PubMed ID: 21756105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The molecular biology of poliovaccines.
    Minor PD
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3065-77. PubMed ID: 1335021
    [No Abstract]   [Full Text] [Related]  

  • 43. Mutational analysis of upstream AUG codons of poliovirus RNA.
    Pelletier J; Flynn ME; Kaplan G; Racaniello V; Sonenberg N
    J Virol; 1988 Dec; 62(12):4486-92. PubMed ID: 2846865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of the secondary structure of 5'-terminal nontranslated segment of RNA from neurovirulent and attenuated strains of poliovirus].
    Blinov VM; Pilipenko EV; Romanova LI; Siniakov AN; Maslova SV
    Dokl Akad Nauk SSSR; 1988; 298(4):1004-6. PubMed ID: 2836148
    [No Abstract]   [Full Text] [Related]  

  • 45. RNA Recombination Enhances Adaptability and Is Required for Virus Spread and Virulence.
    Xiao Y; Rouzine IM; Bianco S; Acevedo A; Goldstein EF; Farkov M; Brodsky L; Andino R
    Cell Host Microbe; 2016 Apr; 19(4):493-503. PubMed ID: 27078068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies.
    Svitkin YV; Maslova SV; Agol VI
    Virology; 1985 Dec; 147(2):243-52. PubMed ID: 3000069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular biology and the control of viral vaccines.
    Minor PD; Macadam A; Cammack N; Dunn G; Almond JW
    FEMS Microbiol Immunol; 1990 Nov; 2(4):207-13. PubMed ID: 2178354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Selective resistance of human neuroblastoma cells to a vaccine strain of poliomyelitis virus].
    Tol'skaia EA; Kolesnikova MS; Drozdov SG; Agol VI
    Dokl Akad Nauk SSSR; 1989; 305(4):987-9. PubMed ID: 2546724
    [No Abstract]   [Full Text] [Related]  

  • 49. [Study on structure and function of poliovirus genomes].
    Nomoto A
    Seikagaku; 1983; 55(1):14-26. PubMed ID: 6302183
    [No Abstract]   [Full Text] [Related]  

  • 50. Distinct modes of poliovirus polyprotein initiation in vitro.
    Pestova TV; Maslova SV; Potapov VK; Agol VI
    Virus Res; 1989 Oct; 14(2):107-18. PubMed ID: 2558458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A replication-defective variant of Sabin 3 poliovirus.
    Tershak DR; Allegretto KD
    Intervirology; 1991; 32(3):127-36. PubMed ID: 1645703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of point mutations in the genome of the poliovirus Sabin vaccine LSc 2ab, and catalogue of RNase T1- and RNase A-resistant oligonucleotides of poliovirus type 1 (Mahoney) RNA.
    Nomoto A; Kitamura N; Lee JJ; Rothberg PG; Imura N; Wimmer E
    Virology; 1981 Jul; 112(1):217-27. PubMed ID: 6264681
    [No Abstract]   [Full Text] [Related]  

  • 53. Mutational robustness and resilience of a replicative cis-element of RNA virus: Promiscuity, limitations, relevance.
    Prostova MA; Gmyl AP; Bakhmutov DV; Shishova AA; Khitrina EV; Kolesnikova MS; Serebryakova MV; Isaeva OV; Agol VI
    RNA Biol; 2015; 12(12):1338-54. PubMed ID: 26488412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cis-element, oriR, involved in the initiation of (-) strand poliovirus RNA: a quasi-globular multi-domain RNA structure maintained by tertiary ('kissing') interactions.
    Pilipenko EV; Poperechny KV; Maslova SV; Melchers WJ; Slot HJ; Agol VI
    EMBO J; 1996 Oct; 15(19):5428-36. PubMed ID: 8895586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Various problems in the molecular biology of picornaviruses].
    Agol VI
    Mol Biol (Mosk); 1977; 11(6):1213-9. PubMed ID: 221803
    [No Abstract]   [Full Text] [Related]  

  • 56. The deletion of 41 proximal nucleotides reverts a poliovirus mutant containing a temperature-sensitive lesion in the 5' noncoding region of genomic RNA.
    Dildine SL; Semler BL
    J Virol; 1989 Feb; 63(2):847-62. PubMed ID: 2536107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Possible mechanism of recombination between RNA-genomes].
    Blinov VM; Romanova LI; Tol'skaia EA; Viktorova EG; Kolesnikova MS
    Dokl Akad Nauk SSSR; 1986; 286(5):1272-5. PubMed ID: 2419070
    [No Abstract]   [Full Text] [Related]  

  • 58. Structure and expression of the picornavirus genome.
    Kitamura N; Adler C; Wimmer E
    Ann N Y Acad Sci; 1980; 354():183-201. PubMed ID: 6261644
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of fatty acids on lipid synthesis and viral RNA replication in poliovirus-infected cells.
    Guinea R; Carrasco L
    Virology; 1991 Nov; 185(1):473-6. PubMed ID: 1656600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Poliovirus mutant that contains a cold-sensitive defect in viral RNA synthesis.
    Berstein HD; Baltimore D
    J Virol; 1988 Aug; 62(8):2922-8. PubMed ID: 2839711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.